GSK plc Buys Back Own Shares

TL;DR

GSK is buying back its own stock via Merrill Lynch.

AI Summary

GSK plc announced on August 28, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Merrill Lynch International. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.

Why It Matters

Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.

Risk Assessment

Risk Level: low — This is a routine disclosure of share repurchases, which is common for publicly traded companies and does not indicate any immediate or significant new risks.

Key Players & Entities

• GSK plc (company) — The company making the share purchases.
• Merrill Lynch International (company) — The corporate stockbroker acting on behalf of GSK plc for the share purchases.
• August 2025 (date) — The period during which the transactions occurred or were reported.

FAQ

Filing Documents

• a9452w.htm (6-K) — 3463KB
• 0001654954-25-010110.txt ( ) — 3465KB

From the Filing

IN OWN SHARES a9452w   UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934       For the month of August 2025   Commission File Number 001-15170     GSK plc (Translation of registrant's name into English)     79 New Oxford Street, London, WC1A 1DG (Address of principal executive office)       Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.   Form 20-F . . . .X. . . . Form 40-F . . . . . . . .       Transaction in own shares   GSK plc (the " Company ") announces today acting through its corporate stockbroker, Merrill Lynch International (the " Broker "), it has purchased the following number of the Company's ordinary shares of 31¼ pence each.       Date of purchase: 27 August 2025 Aggregate number of ordinary shares of 31¼ pence each purchased: 260,986 Lowest price paid per share (GBp): 1,471.00p Highest price paid per share (GBp): 1,484.00p Volume-weighted average price paid per share (GBp): 1,477.76p     The purchased shares will be held as Treasury shares.   Such purchase forms part of the Company's existing buyback programme and was effected pursuant to the non-discretionary agreement entered into with the Broker on 4 June 2025, as announced on 4 June 2025. Since 4 June 2025 the Company has purchased 25,785,333 ordinary shares.   Following the above purchase, the Company will hold 243,919,716 ordinary shares in treasury and have 4,071,472,911 ordinary shares in issue (excluding Treasury shares).   The total number of voting rights in the Company is 4,071,472,911. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.   The Company confirms that, in accordance with DTR 5.5.1R, following the above purchase the percentage of voting rights attributable to the ordinary shares held in treasury is 5.99 per cent.   The table below contains detailed information of the individual trades made by the Broker on the London Stock Exchange and the CBOE Europe Limited recognised investment exchange (through its order books having market identification codes CHIX or BATE) as part of the buyback programme.       Schedule of Purchases   Shares purchased:       GSK plc (ISIN: GB00BN7SWP63)   Date of purchases:       27 August 2025   Investment firm:          Merrill Lynch International       Aggregated information per trading venue:   Venue Number of ordinary shares purchased Highest price paid (per ordinary share) (GBp) Lowest price paid (per ordinary share) (GBp) Volume weighted average price paid (per ordinary share) (GBp) London Stock Exchange (XLON) 260,986 1,484.00p 1,471.00p 1,477.76p CBOE (CHIX) 0 - - - CBOE (BATE) 0 - - -     Individual transactions:   Number of Shares Price per Share (GBp) Trading venue Date of transaction Time of transaction Transaction reference number 9 1,476.50  XLON 27-Aug-2025 08:00:03 0XL061400000000088VRVB 9 1,476.50  XLON 27-Aug-2025 08:00:03 0XL061700000000088VS0V 10 1,476.50  XLON 27-Aug-2025 08:00:03 0XL061400000000088VRVD 10 1,476.50  XLON 27-Aug-2025 08:00:03 0XL061400000000088VRVE 10 1,476.50  XLON 27-Aug-2025 08:00:03 0XL061700000000088VS10 10 1,476.50  XLON 27-Aug-2025 08:00:03 0XL06D000000000088VRUB 11 1,476.50  XLON 27-Aug-2025 08:00:03 0XL061700000000088VS0U 11 1,478.00  XLON 27-Aug-2025 08:00:03 0XL061400000000088VRV2 11 1,478.00  XLON 27-Aug-2025 08:00:03 0XL061700000000088VS0S 12 1,476.50  XLON 27-Aug-2025 08:00:03 0XL061100000000088VRV0 12 1,476.50  XLON 27-Aug-2025 08:00:03 0XL061100000000088VRV1 12 1,476.50  XLON 27-Aug-2025 08:00:03 0XL067000000000088VRS6 12 1,478.00  XLON 27-Aug-2025 08:00:03 0XL061400000000088VRV6 12 1,478.00  XLON 27-Aug-2025 08:00:03 0XL061700000000088VS0L 12 1,478.00  XLON 27-Aug-2025 08:00:03 0XL061700000000088VS0N 12 1,478.00  XLON 27-Aug-2025 08:00:03 0XL06D000000000088VRU6 13 1

View Full Filing

View this 6-K filing on SEC EDGAR